Rojas Juan I, Patrucco Liliana, Cristiano Edgardo
Multiple Sclerosis Center of Buenos Aires, Neurology Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Degener Neurol Neuromuscul Dis. 2014 Jun 20;4:103-109. doi: 10.2147/DNND.S46557. eCollection 2014.
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Recent developments have led to newer therapeutic options for disease treatment. A few studies have reported MS prevalence rates between 12 and 20 per 100,000 inhabitants nationwide in Argentina, and an incidence of 1.76 cases per 100,000 inhabitants per year. Considering the epidemiology of MS in Argentina, the total number of patients affected is estimated at 5,000-8,000 patients, with nearly 55%-65% of patients having a relapsing-remitting MS subtype of the disease. The aim of this review is to provide an overview of current and emerging treatments available in Argentina for patients with MS.
多发性硬化症（MS）是一种中枢神经系统的自身免疫性疾病。最近的进展带来了用于疾病治疗的更新的治疗选择。一些研究报告称，在阿根廷全国范围内，MS的患病率为每10万居民中有12至20例，发病率为每年每10万居民中有1.76例。考虑到阿根廷MS的流行病学情况，估计受影响患者的总数为5000 - 8000名患者，其中近55% - 65%的患者患有复发缓解型MS亚型疾病。本综述的目的是概述阿根廷目前可用于MS患者的现有和新兴治疗方法。
